Romu Corbau

Despite major advances in ocular drug delivery, one of the biggest challenges remains human behaviour, the burden of compliance only grows. This panel explores how clinical design, technology innovation, and long-acting delivery platforms are being used to overcome the realities of poor adherence.

• Why do non-invasive approaches like eye drops still fail, despite being preferred by patients? What are the limits of patient compliance in real-world use?
• How can we reduce injection burden when chronic treatment still demands frequent visits? Is specialist training part of the problem?
• Are tracking tools: apps, sensors, reminders effective at improving adherence?
• Can we create long-lasting kinetics without compromising safety or adding surgical complexity?
• Are regulatory and manufacturing hurdles (CMC, scale-up, sterilization) the hidden barriers to achieving durable compliance solutions?